Gastrointestinal stromal tumors (GIST) of the small bowel: High-risk pathologic features predict the need for adjuvant therapy

被引:0
|
作者
Hassan, Imran
You, Yi-Qian N.
Shyyan, Roman
Dozois, Eric J.
Okuno, Scott H.
Smyrk, Thomas C.
Donohue, John H.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A890 / A890
页数:1
相关论文
共 50 条
  • [31] Endoscopic Removal of Small Gastrointestinal Stromal Tumors: Can We GIST-ify the Risk?
    Marshall, Christopher A.
    Hyatt, Benjamin J.
    Wassef, Wahid
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (07) : 1815 - 1817
  • [32] Endoscopic Removal of Small Gastrointestinal Stromal Tumors: Can We GIST-ify the Risk?
    Christopher A. Marshall
    Benjamin J. Hyatt
    Wahid Wassef
    Digestive Diseases and Sciences, 2010, 55 : 1815 - 1817
  • [33] Trends in Utilization of Multimodal Therapy for Gastric and Small Bowel Gastrointestinal Stromal Tumors
    Bansal, S.
    Portuondo, J. I.
    Cao, H. S. Tran
    Sada, Y. H.
    Roland, C.
    Chai, C.
    Massarweh, N. N.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S140 - S141
  • [34] Adjuvant imatinib therapy of 208 gastrointestinal stromal tumor (GIST) patients: Dose, duration, and risk assessment
    Trent, J. C.
    von Mehren, M.
    Pisters, P. W.
    Stealey, E.
    Sirulnik, L. A.
    Blanks, C. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [35] Multidetector CT of high-risk patients with occult gastrointestinal stromal tumors
    Nishida, T
    Kumano, S
    Sugiura, T
    Ikushima, H
    Nishikawa, K
    Ito, T
    Matsuda, H
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2003, 180 (01) : 185 - 189
  • [36] Neoadjuvant gleevec is effective in the treatment of high-risk gastrointestinal stromal tumors
    Arciero, C
    Watson, JC
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 28 - 29
  • [37] Remarkable prognostic heterogeneity justifies subdividing high-risk gastrointestinal stromal tumors (GIST) of NIH consensus scheme into two different risk groups
    Li, CF
    Huang, WW
    Lin, CN
    Lu, D
    Huang, HY
    MODERN PATHOLOGY, 2006, 19 : 112A - 112A
  • [38] Remarkable prognostic heterogeneity justifies subdividing high-risk gastrointestinal stromal tumors (GIST) of NIH consensus scheme into two different risk groups
    Li, CF
    Huang, WW
    Lin, CN
    Lu, D
    Huang, HY
    LABORATORY INVESTIGATION, 2006, 86 : 112A - 112A
  • [39] ADJUVANT POST-SURGERY THERAPY WITH IMATINIB IN INTERMEDIATE OR HIGH-RISK GASTROINTESTINAL STROMAL TUMOUR (GIST) PATIENTS: INTERIM ANALYSIS FROM A SINGLE CENTRE COMPARISON STUDY
    Shen, L.
    Li, J.
    Li, J.
    Gong, J.
    Wu, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 267 - 267
  • [40] Endoscopic Characteristics, Risk Grade, and Prognostic Prediction in Gastrointestinal Stromal Tumors of the Small Bowel
    Nakano, Arihiro
    Nakamura, Masanao
    Watanabe, Osamu
    Yamamura, Takeshi
    Funasaka, Kohei
    Ohno, Eizaburo
    Kawashima, Hiroki
    Miyahara, Ryoji
    Goto, Hidemi
    Hirooka, Yoshiki
    DIGESTION, 2017, 95 (02) : 122 - 131